05/04/2026 | Press release | Distributed by Public on 05/04/2026 09:07
"Today's ruling by the Fifth Circuit, which temporarily halts providers' ability to prescribe mifepristone through telemedicine and send those pills by mail, is deeply troubling.
"Mifepristone is a safe, FDA-approved drug, and has been used by millions of people across our country for decades. We will use every tool available to defend Oregonians' access to mifepristone and other essential healthcare. We call on the Fifth Circuit or Supreme Court to immediately stay today's ruling."